journal article·2022-12Open access

Cerium dioxide nanoparticles synthesized via precipitation at constant pH: Synthesis, physical-chemical and antioxidant properties

Yuliia Shlapa, Serhii Solopan, Veronika Sarnatskaya, Katarina Siposova, Ivana Garcarova, Katerina Veltruska, Illia Timashkov, Oleksandra Lykhova, Denis Kolesnik, Andrey Musatov, Vladimir Nikolaev, Anatolii Belous

Abstract

Cerium oxide nanoparticles (CeO2 NPs) are well known for their application in various fields of industry, as well as in biology and medicine. Knowledge of synthesis schemes, physicochemical and morphological features of nanoscale CeO2 is important for assessing their antioxidant behavior and understanding the mechanism of oxidative stress and its consequences. The choice of the method of synthesis should be based on the possibility to choose the conditions and parameters for obtaining CeO2 with controlled dimensions and a ratio of Се3+/Се4+ on their surface. In this study, CeO2 NPs are synthesized by precipitation in mixed water-alcohol solutions at constant pH = 9. The properties of obtained NPs are studied using various methods of physical-chemical characterization such as X-ray diffraction, X-ray photoelectron spectroscopy, transmission electron microscopy, and dynamic light scattering. The size of CeO2 NPs varied from 14 to 4.2 nm with increasing alcohol concentration, while the effect of constant pH during synthesis on the morphology of the particles was insignificant. The synthesized nanoparticles form highly stable aqueous suspensions since their zeta-potential is higher than + 40 mV. It is found that the ability of CeO2 NPs to self-stabilize is associated with the presence of hydrated Ce4+ ions on their surface. In vitro biological studies have shown that, regardless of particle size, CeO2 NPs have antioxidant potential, but smaller NPs with a higher percentage of Ce3+ on the surface had a more effective antioxidant effect. In addition, the size-depended activity of CeO2 NPs to inhibit the amyloid formation of insulin is demonstrated.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (93)

Show source-provided references
1. Nanomaterial properties: size and shape dependencies10.1155/2012/180976 ↗
2. P. Holister, J.W. Weener, C. Roman, T. Harper, Nanoparticles. Technol White Papers, 3, 2003, pp. 1–11.
3. Applications of inorganic nanoparticles as therapeutic agents10.1088/0957-4484/25/1/012001 ↗
4. Inorganic nanoparticles: a potential cancer therapy for human welfare10.1016/j.ijpharm.2018.01.034 ↗
5. Oxidative stress: oxidants and antioxidants10.1113/expphysiol.1997.sp004024 ↗
7. Nanoparticles in medicine: therapeutic applications and developments10.1038/sj.clpt.6100400 ↗
8. Inorganic nanoparticles with enzyme-mimetic activities for biomedical applications10.1016/j.ccr.2019.213092 ↗
9. Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases10.1016/j.jconrel.2016.05.044 ↗
10. Oxidative stress and apoptosis: impact on cancer therapy10.1002/jps.20874 ↗
11. Oxidative stress as a precursor to the irreversible hepatocellular injury caused by hyperthermia10.3109/02656739109056444 ↗
12. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease10.1016/j.pneurobio.2005.02.004 ↗
13. Synthesis and encapsulation of V (IV, V) compounds in silica nanoparticles targeting development of antioxidant and antiradical nanomaterials10.1016/j.jinorgbio.2018.12.005 ↗
14. Antioxidant inorganic nanoparticles and their potential applications in biomedicine10.1016/B978-0-12-814156-4.00011-2 ↗
15. Antioxidant activity of nanomaterials10.1039/C8TB00107C ↗
16. Nanostructured ceria-based materials: synthesis, properties, and applications10.1039/c2ee22310d ↗
17. Evaluation of in vitro cytotoxicity, biocompatibility, and changes in the expression of apoptosis regulatory proteins induced by cerium oxide nanocrystals10.1080/14686996.2017.1319731 ↗
18. Biomimetic and antioxidant activity of nanocrystalline cerium dioxide10.26724/2079-8334-2018-1-63-196-201 ↗
19. Biological activity of cerium dioxide nanoparticle10.1002/jbm.a.36936 ↗
20. Fundamentals and catalytic applications of CeO2-based materials10.1021/acs.chemrev.5b00603 ↗
21. Facet-dependent reactivity of ceria nanoparticles exemplified by CeO2-based transition metal catalysts: A critical review10.3390/catal11040452 ↗
22. Controlling the surface chemistry of cerium oxide nanoparticles for biological applications10.1039/C6TB00396F ↗
23. Ce3+ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles10.1021/nn200126a ↗
24. Pharmacological potential of cerium oxide nanoparticles10.1039/c0nr00875c ↗
25. Polyhedral CeO2 nanoparticles: size-dependent geometrical and electronic structure.10.1021/jp300342b ↗
26. Structural and physical-chemical characterization of redox active CeO2 nanoparticles synthesized by precipitation in water-alcohol solutions10.1088/1361-6528/abf7e9 ↗
27. DLS and zeta potential–what they are and what they are not?10.1016/j.jconrel.2016.06.017 ↗
28. Nanoparticle characterization: what to measure?10.1002/adma.201901556 ↗
29. Synthesis of positively and negatively charged CeO2 nanoparticles: investigation of the role of surface charge on growth and development of Drosophila melanogaster10.1021/acsomega.8b02747 ↗
30. Targeted delivery and redox activity of folic acid-functionalized nanoceria in tumor cells10.1021/acs.molpharmaceut.7b00920 ↗
31. Synthesis of biocompatible dextran‐coated nanoceria with pH‐dependent antioxidant properties10.1002/smll.200700824 ↗
32. Effects of the synthesis methods on the physicochemical properties of cerium dioxide powder10.1016/j.colsurfa.2006.12.042 ↗
33. Structure and magnetic properties of synthesized fine cerium dioxide nanoparticles10.1016/j.jallcom.2018.04.115 ↗
34. Synthesis and catalytic properties of CeO2 and Co/CeO2 nanofibres for diesel soot combustion10.1016/j.cattod.2011.12.025 ↗
35. Hydrothermal synthesis of CeO2 nano-particles10.1016/j.jmatprotec.2007.02.042 ↗
36. Synthesis of CeO2 nanoparticles by precipitation in reversal microemulsions and their physical–chemical and biological properties10.1007/s00339-019-2706-6 ↗
37. Novel synthesis of nanocrystalline CeO2 by mechanochemical and water-in-oil microemulsion methods10.1016/j.matlet.2006.04.013 ↗
38. A green approach for the synthesis of a cerium oxide nanoparticle: characterization and antibacterial activity10.1142/S0219581X14500185 ↗
39. Cerium oxide nanoparticles: green synthesis and biological applications10.2147/IJN.S124855 ↗
40. Visible light removal of reactive dyes using CeO2 synthesized by precipitation10.1016/j.jece.2018.06.046 ↗
41. Reactive cerium (IV) oxide powders by the homogeneous precipitation method10.1111/j.1151-2916.1993.tb03942.x ↗
42. A size-controllable precipitation method to prepare CeO2 nanoparticles in a membrane dispersion microreactor.10.1021/acs.iecr.7b00289 ↗
43. The effect of precipitant on co-precipitation synthesis of yttrium aluminum garnet powders10.1016/j.ceramint.2012.05.066 ↗
44. Description and survey of methodologies for the determination of amorphous content via X-ray powder diffraction10.1524/zkri.2011.1437 ↗
45. X-ray analysis of ZnO nanoparticles by Williamson–Hall and size–strain plot methods10.1016/j.solidstatesciences.2010.11.024 ↗
46. Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide10.1063/1.2061873 ↗
47. F. Zhang, P. Wang, J. Koberstein, S. Khalid, S.W. Chan, Cerium oxidation state in ceria nanoparticles studied with X-ray photoelectron spectroscopy and absorption near edge spectroscopy. 563(1–3), 2004, pp. 74–82. 〈https://doi.org/10.1016/j.susc.2004.05.138〉.10.1016/j.susc.2004.05.138 ↗
48. Freshney · 2010 · 163
49. Photometric method for the determination of low concentrations of hydrogen peroxide by the peroxidase catalyzed oxidation of N,N-diethyl-p-phenylenediamine (DPD)10.1016/0043-1354(88)90005-X ↗
50. Inhibition of amyloid fibril formation and disassembly of pre-formed fibrils by natural polyphenol rottlerin10.1016/j.bbapap.2018.10.002 ↗
51. Dual effect of non-ionic detergent Triton X-100 on insulin amyloid formation10.1016/j.colsurfb.2018.10.039 ↗
52. Complementary experimental and computational analysis of the effects of non-ionic detergents and phospholipids on insulin amyloid aggregation
53. Flow in porous media I: A theoretical derivation of Darcy's law10.1007/BF01036523 ↗
54. Facile preparation of CeO2 microspheres with high surface area by ultrasonic spray pyrolysis10.1515/gps-2017-0041 ↗
55. STM and XPS study of CeO2(111) reduction by atomic hydrogen10.1016/j.susc.2014.05.008 ↗
56. Coprecipitation and adsorption rules10.1039/sa9720900264 ↗
57. Effective ionic radii in oxides and fluorides10.1107/S0567740869003220 ↗
58. Biochars and their magnetic derivatives as enzyme-like catalysts mimicking peroxidases10.1007/s42773-020-00035-5 ↗
59. Dual-functional antioxidant and antiamyloid cerium oxide nanoparticles fabricated by controlled synthesis in water-alcohol solutions10.3390/biomedicines10050942 ↗
60. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles10.1039/b615134e ↗
61. The role of cerium redox state in the SOD mimetic activity of nanoceria10.1016/j.biomaterials.2008.03.014 ↗
62. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons10.1016/j.biomaterials.2006.11.036 ↗
63. Protein quality control under oxidative stress conditions10.1016/j.jmb.2015.02.014 ↗
64. Molecular changes in the postmortem parkinsonian brain10.1111/jnc.13696 ↗
65. Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia10.1074/jbc.C500238200 ↗
66. Causative links between protein aggregation and oxidative stress: a review10.3390/ijms20163896 ↗
67. Protein-nanoparticle interactions10.1016/S1748-0132(08)70014-8 ↗
68. Nucleation of protein fibrillation by nanoparticles10.1073/pnas.0701250104 ↗
69. Nanoparticles as catalysts for protein fibrillation10.1073/pnas.0703194104 ↗
70. Depolymerization of insulin amyloid fibrils by albumin-modified magnetic fluid10.1088/0957-4484/23/5/055101 ↗
71. Nanomaterials for reducing amyloid cytotoxicity10.1002/adma.201301210 ↗
72. Acceleration and inhibition of amyloid-β fibril formation by peptide-conjugated fluorescent-maghemite nanoparticles10.1007/s11051-011-0276-4 ↗
73. Nanoparticle assisted magnetic resonance imaging of the early reversible stages of amyloid β self-assembly10.1039/b803294g ↗
74. A localized surface plasmon resonance biosensor: first steps toward an assay for Alzheimer's disease10.1021/nl049670j ↗
75. Cerium oxide nanoparticles trigger neuronal survival in a human Alzheimer disease model by modulating BDNF pathway10.2174/157341309788185523 ↗
76. Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution10.1021/cn300196n ↗
77. Advances in the study of cerium oxide nanoparticles: New insights into antiamyloidogenic activity10.1021/acsabm.8b00816 ↗
78. TiO2 nanoparticles promote β-amyloid fibrillation in vitro10.1016/j.bbrc.2008.06.035 ↗
79. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: detection of amyloid aggregation in solution10.1002/pro.5560020312 ↗
80. Binding mode of Thioflavin T in insulin amyloid fibrils10.1016/j.jsb.2007.06.004 ↗
81. Thioflavin T derivatives for the characterization of insulin and lysozyme amyloid fibrils in vitro: Fluorescence and quantum-chemical studies10.1016/j.jlumin.2014.10.042 ↗
82. Effect of the fluorescent probes ThT and ANS on the mature amyloid fibrils10.1080/19336896.2020.1720487 ↗
83. The molecular mass of dextran used to modify magnetite nanoparticles affects insulin amyloid aggregation10.1016/j.jmmm.2016.10.083 ↗
84. Influence of nanoparticle size and shape on oligomer formation of an amyloidogenic peptide10.1021/jz200330k ↗
85. The size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-β fibrillation10.1039/C7NR00699C ↗
86. How do the size, charge and shape of nanoparticles affect amyloid β aggregation on brain lipid bilayer?10.1038/srep19548 ↗
87. The roles of gold nanoparticles in the detection of amyloid-β peptide for Alzheimer's disease10.1016/j.colcom.2021.100579 ↗
88. The effect of nanoparticles on amyloid aggregation depends on the protein stability and intrinsic aggregation rat10.1021/la203078w ↗
89. Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer’s disease amyloid-β protein aggregation10.1186/s13036-017-0047-6 ↗
90. Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity10.2147/IJN.S220380 ↗
91. Nano-particle mediated inhibition of Parkinson’s disease using computational biology approach10.1038/s41598-018-27580-1 ↗
92. Antiamyloid activity of functionalized cerium oxide nanoparticle on lysozyme fibrillation: spectroscopic and microscopic investigation10.1016/j.mtla.2019.100285 ↗
93. Europium-doped cerium oxide nanoparticles for microglial amyloid beta clearance and homeostasis10.1021/acschemneuro.1c00847 ↗